EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature. (Q40543886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

24 February 2020

main subject

vitamin D

0 references

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Zabihollah Shoja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Shohreh Shahmahmoudi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Abbas Mirshafiey

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mohammad Ali Sahraian

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

9

Rozita Doosti

1 reference

24 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

Ahmad Nejati

1

object named as

Ahmad Nejati

1 reference

24 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

author name string

Abbas Tafakhori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Yaghoub Mollaei-Kandelous

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Farhad Rezaei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kabir Magaji Hamid

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mahmood Mahmoudi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Fazel Shokri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sayed Mahdi Marashi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

13 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

Medical Microbiology and Immunology

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

143-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26365612%20AND%20SRC:MED&resulttype=core&format=json

The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Genetics of multiple sclerosis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

21 January 2018

12 December 2020

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Environmental triggers of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Immunopathogenesis and immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D as a protective factor in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Epstein-Barr virus, latitude and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Understanding the joint effects of EBV and vitamin D in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Clinical implications of a possible role of vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Antiviral immune responses: triggers of or triggered by autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D as an immune modulator in multiple sclerosis, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Cytokines in multiple sclerosis: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: prospective clinical and MRI follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Regulatory T cells in autoimmune neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D and Serum Cytokines in a Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D and autoimmune thyroid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Does vitamin D affect risk of developing autoimmune disease?: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Editorial: CD73 deficiency and immune dysregulation in HIV infection: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Ecto-5'-nucleotidase (CD73) regulates host inflammatory responses and exacerbates murine salmonellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

CD73 and adenosine generation in the creation of regulatory microenvironments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0437-7

Sex differences in cytokine responses to myelin peptides in multiple sclerosis

21 January 2018

1 reference

12 December 2020

IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions

1 reference

12 December 2020

Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls.

1 reference

12 December 2020

Cytokines as biomarkers in rheumatoid arthritis

1 reference

12 December 2020

Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-17 in transverse myelitis and multiple sclerosis

1 reference

12 December 2020

Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS

1 reference

12 December 2020

Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay

1 reference

12 December 2020